Ownership history in BAILARD, INC. · 4 quarters on record
This page tracks every 13F SEC filing in which BAILARD, INC. reported a position in VANDA PHARMACEUTICALS INC (VNDA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 26,169 | +69 | +0.3% | 0.00% | $131K | $4.99 |
| 2025 Q2 | ADDED | 26,100 | +3,631 | +16.2% | 0.00% | $123K | $4.72 |
| 2025 Q1 | REDUCED | 22,469 | -3,831 | -14.6% | 0.00% | $103K | $4.59 |
| 2023 Q4 | INITIATED | 26,300 | — | — | 0.00% | $111K | — |
As of 2025 Q4 — sorted by position size